|
Transgenomic Announces Pricing of Public Offering of Common Stock
MarketWatch OMAHA, Neb., Feb 27, 2015 (BUSINESS WIRE) — Transgenomic, Inc. TBIO, +1.84% today announced the pricing of an underwritten public offering of 3,573,899 shares of the company’s common stock and corresponding warrants to purchase 714,780 shares … Transgenomic Announces Commencement of Public Offering of Common StockPharmiWeb.com (press release) |
